Three Los Angeles-based Cedars-Sinai investigators developed a method to harness stem cells to regrow tissue damaged by major trauma. The Department of Defense and National Institutes of Health awarded the researchers $8 million in grants.
Biologics
Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.
Vertebral body mesenchymal stem cells derived from whole bone marrow aspirate may provide alternative stem cell sources for spine surgery applications, according to a study in Spine.
LifeNet Health launched the PliaFX Prime allograft surgical solution.
Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.
Advertisement
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).
Reinvent Biologics is a regenerative medicine company.
Platelet-rich plasma injections and stem cell therapies are ushering in a "new dawn" in orthopedics, according to Jason Arora, DO, a board-certified interventional spine and pain management physician at West Orange, N.J.-based Atlantic Spine Center.
Cynata Therapeutics entered into a licensing agreement with Fujifilm Holdings to begin stem cell therapy clinical trials in the U.S. and Japan, according to Nikkei Asian Review.
New York City-based Hospital for Special Surgery researchers launched a clinical trial to assess the effects of Organogenesis' ReNu on knee function.